Gilead gets subpoena from Justice Department
MarketWatch
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
The 10 Best Values in Pharma and Biotech
Motley Fool
J&J Approved, But Needs Help From a Friend
Motley Fool
Gilead Q1 profit dips to $651.1M
Bizjournals.com

